785 related articles for article (PubMed ID: 23545506)
1. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
3. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
4. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
Hassan S; Mittal C; Amer S; Khalid F; Patel A; Delbusto R; Samuel L; Alangaden G; Ramesh M
Transpl Infect Dis; 2014 Feb; 16(1):55-60. PubMed ID: 24283677
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
6. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
7. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
[TBL] [Abstract][Full Text] [Related]
8. Systematic screening of BK virus by real-time PCR prevents BK virus associated nephropathy in renal transplant recipients.
Hammarin AL; Öqvist B; Wahlgren J; Falk KI
J Med Virol; 2011 Nov; 83(11):1959-65. PubMed ID: 21915871
[TBL] [Abstract][Full Text] [Related]
9. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
Westphal SG; Lyden ER; Langewisch ED; Miles CD
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
[TBL] [Abstract][Full Text] [Related]
10. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
Mindlova M; Boucek P; Saudek F; Skibova J; Jedinakova T; Lipar K; Adamec M; Hirsch HH
Clin Transplant; 2012; 26(2):267-74. PubMed ID: 21854452
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.
Soleymanian T; Keyvani H; Jazayeri SM; Fazeli Z; Ghamari S; Mahabadi M; Chegeni V; Najafi I; Ganji MR
Iran J Kidney Dis; 2014 Mar; 8(2):145-51. PubMed ID: 24685738
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy.
Chung BH; Hong YA; Kim HG; Sun IO; Choi SR; Park HS; Lee SH; Choi BS; Park CW; Choi YJ; Kim YS; Yang CW
Transpl Int; 2012 Jun; 25(6):687-95. PubMed ID: 22509924
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
18. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
19. Prospective monitoring of BK virus replication in renal transplant recipients.
Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
[TBL] [Abstract][Full Text] [Related]
20. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.
Nickeleit V; Klimkait T; Binet IF; Dalquen P; Del Zenero V; Thiel G; Mihatsch MJ; Hirsch HH
N Engl J Med; 2000 May; 342(18):1309-15. PubMed ID: 10793163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
